Giuseppe Accogli net worth and biography

Giuseppe Accogli Biography and Net Worth

Giuseppe Accogli, age 50, is Senior Vice President and President, Americas. Prior to his current role, Mr. Accogli served as Senior Vice President and President, Global Businesses, from 2017 to 2019. He also served as Corporate Vice President and President, Renal from 2016 to 2017 and as Head of the U.S. region for Baxter’s Renal business from 2015 to 2016. Mr. Accogli joined Baxter in 2007 as Renal business unit Director in Italy, and assumed positions of increasing responsibility with the Renal business in Europe, including Head of the EMEA region for Renal from 2013 to 2015. Previously he worked as a Business Unit Manager and Sales and Marketing Manager for Medtronic plc in Italy, and in several sales, product and marketing roles for Tyco and then Covidien in Italy and EMEA. Mr. Accogli has served as a director to AdvaMed, an American medical device trade association, since September 25, 2019. Provided by Tagnifi.

What is Giuseppe Accogli's net worth?: The estimated net worth of Giuseppe Accogli is at least $3.02 million as of June 19th, 2020. Mr. Accogli owns 76,473 shares of Baxter International stock worth more than $3,018,389 as of April 20th. This net worth approximation does not reflect any other assets that Mr. Accogli may own. Learn More about Giuseppe Accogli's net worth.
How do I contact Giuseppe Accogli?: The corporate mailing address for Mr. Accogli and other Baxter International executives is One Baxter Parkway DF2-1W, Deerfield IL, 60015. Baxter International can also be reached via phone at (224) 948-2000 and via email at [email protected]. Learn More on Giuseppe Accogli's contact information.
Has Giuseppe Accogli been buying or selling shares of Baxter International?: Giuseppe Accogli has not been actively trading shares of Baxter International during the past quarter. Most recently, Giuseppe Accogli sold 72,341 shares of the business's stock in a transaction on Friday, June 19th. The shares were sold at an average price of $85.00, for a transaction totalling $6,148,985.00. Following the completion of the sale, the senior vice president now directly owns 76,473 shares of the company's stock, valued at $6,500,205. Learn More on Giuseppe Accogli's trading history.
Who are Baxter International's active insiders?: Baxter International's insider roster includes Giuseppe Accogli (SVP), John Forsyth (Director), Andrew Frye (SVP), James Gavin, III (Director), Jacqueline Kunzler (SVP), Sean Martin (SVP), Jeanne Mason (SVP), Brian Stevens (CAO), and Albert Stroucken (Director). Learn More on Baxter International's active insiders.

Giuseppe Accogli Insider Trading History at Baxter International

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
6/19/2020	Sell	72,341	$85.00	$6,148,985.00	76,473
3/18/2019	Sell	38,297	$76.78	$2,940,443.66	70,001
9/17/2018	Sell	17,647	$77.27	$1,363,583.69	59,452
1/2/2018	Sell	28,641	$67.00	$1,918,947.00
8/17/2017	Sell	12,670	$60.96	$772,363.20	33,286

Giuseppe Accogli Buying and Selling Activity at Baxter International

Baxter International Company Overview

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories. It also provides administrative sets; adhesion prevention products; inhaled anesthesia; drug compounding; chronic and acute dialysis therapies and services, including peritoneal dialysis (PD), hemodialysis (HD), continuous renal replacement therapies (CRRT), and other organ support therapies. The company's products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic products; and a collaborative research agreement with Miromatrix Medical Inc. aiming to advance care for patients with acute liver failure. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.

Today's Range

Now: $39.47

$39.39

$40.08

50 Day Range

MA: $41.80

$39.47

$43.77

2 Week Range

Now: $39.47

$31.01

$50.21

Volume

2,788,110 shs

Average Volume

3,682,726 shs

Market Capitalization

$20.04 billion

P/E Ratio

7.56

Dividend Yield

2.93%

Beta

0.62

Biden’s $374B Giveaway Into This Sector

From DTI | Ad

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story